You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

40 Results
Drug
Other Name(s): Nexavar®
Jul 2023
Drug
Other Name(s): Tasigna®
Dec 2023
Drug
Other Name(s): Sutent®
Sep 2023
Drug
Other Name(s): Caprelsa®
Aug 2023
Drug
Other Name(s): Zelboraf ®
Aug 2023
Drug
Other Name(s): Stivarga®
Nov 2023
Drug
Other Name(s): Erivedge®
Oct 2023
Drug
Other Name(s): Pomalyst®
Aug 2023
Drug
Other Name(s): Imbruvica®
Feb 2023
Drug
Other Name(s): Iclusig®
Aug 2023
Drug
Other Name(s): Lenvima®
Sep 2023
Regimen
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Intent: Palliative
Funding:
Exceptional Access Program
    SORAfenib - Advanced hepatocellular carcinoma, with specific criteria
Mar 2023

Pages